UCSF Helen Diller Family Comprehensive Cancer Center

Researchers from UCSF discovered that a combination of immunotherapies can reprogram the immune environment of colon cancer tumors in the liver.

UCSF researchers have discovered that the cells of triple-negative breast cancer tumors build molecular tunnels into nearby fat cells.

A protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body.

Researchers at UC San Francisco discovered that some gut bacteria reduce the side effects of chemotherapy and that some drugs boost protective bacteria.

UCSF experts highlight leadership in innovative cancer research and education.

Targeted therapy, genomics, and treatment disparities were among the topics that were presented by researchers from UCSF at the 2024 AACR conference.

A genetic mutation that makes cancer cells hardy can be engineered into T cells, giving them superhuman strength.

A national survey conducted by UCSF researchers reveals that many physicians are unfamiliar with how the FDA regulates new drugs and medical devices.